GreenGate Partners advises Redalpine on € 37.6 million Series B deal from Sanity Group
Munich — Sanity Group has successfully closed Europe’s largest cannabis financing round with a Series B financing of EUR 37.6 million. British American Tobacco Group led the round, which brings the total investment in Sanity Group to over EUR 100 million. GreenGate Partners assisted the Swiss venture capital fund Redalpine in extending its commitment.
Sanity Group has set a new record in the growing cannabis industry in Europe with a EUR 37.6 million Series B financing round. This round was led by British American Tobacco Group through BT DE Investments Inc. listed. In addition, other existing investors have again participated.
Sanity Group is Germany’s leading health and wellness cannabis company. Founded in 2018, the company now employs about 120 people in the medical, consumer health and scientific fields. Sanity Group’s stated goal is to improve the overall quality of life through medicines, medical devices and consumer products made from can- nabinoids.
Advisor Redalpine: GreenGate Partners advised the Swiss venture capital fund Redalpine on the expansion of its investment in the financing round.
GreenGate Partners ’ corporate team specializes, among other things, in the venture capital industry. The lawyers of GreenGate Partners have been advising Redalpine for a long time on investments and shareholdings in companies in a wide range of industries.